share_log

UnitedHealth | 8-K/A: The Company's Compensation and Human Resources Committee Has Approved Compensation to Mr. Rex (Amendment)

UnitedHealth | 8-K/A: The Company's Compensation and Human Resources Committee Has Approved Compensation to Mr. Rex (Amendment)

聯合健康 | 8-K/A:公司的薪酬和人力資源委員會已批准對雷克斯先生的薪酬(修正)
美股sec公告 ·  04/17 16:11
Moomoo AI 已提取核心訊息
UnitedHealth Group Incorporated filed an amendment to its original Form 8-K report with the SEC on April 17, 2024. The amendment pertains to the compensation package approved by the Company's Compensation and Human Resources Committee for Mr. Rex. The updated compensation includes an annual base salary of $1,400,000, an annual cash incentive with a target value of 200% of his base salary, and grants of stock awards valued at $600,000, which include stock options, restricted stock units, and performance shares. This amendment follows the initial report filed on March 28, 2024, and does not affect other aspects of Mr. Rex's compensation.
UnitedHealth Group Incorporated filed an amendment to its original Form 8-K report with the SEC on April 17, 2024. The amendment pertains to the compensation package approved by the Company's Compensation and Human Resources Committee for Mr. Rex. The updated compensation includes an annual base salary of $1,400,000, an annual cash incentive with a target value of 200% of his base salary, and grants of stock awards valued at $600,000, which include stock options, restricted stock units, and performance shares. This amendment follows the initial report filed on March 28, 2024, and does not affect other aspects of Mr. Rex's compensation.
UnitedHealth Group Incorporated 於 2024 年 4 月 17 日向美國證券交易委員會提交了其最初的 8-K 表報告的修正案。該修正案涉及公司薪酬和人力資源委員會爲雷克斯先生批准的薪酬待遇。更新後的薪酬包括140萬美元的年基本工資,目標值爲其基本工資的200%的年度現金激勵,以及價值60萬美元的股票獎勵,其中包括股票期權、限制性股票單位和績效股票。該修正案遵循了2024年3月28日提交的初步報告,不影響雷克斯薪酬的其他方面。
UnitedHealth Group Incorporated 於 2024 年 4 月 17 日向美國證券交易委員會提交了其最初的 8-K 表報告的修正案。該修正案涉及公司薪酬和人力資源委員會爲雷克斯先生批准的薪酬待遇。更新後的薪酬包括140萬美元的年基本工資,目標值爲其基本工資的200%的年度現金激勵,以及價值60萬美元的股票獎勵,其中包括股票期權、限制性股票單位和績效股票。該修正案遵循了2024年3月28日提交的初步報告,不影響雷克斯薪酬的其他方面。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息